Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors

Aromatase (CYP19) is a critical enzyme for estrogen biosynthesis, and aromatase inhibitors (AIs) are established endocrine therapy for post-menopausal women with breast cancer. DNA samples were obtained from 52 women pre- and post-AI treatment in the neoadjuvant setting. 82 breast cancer and 19 norm...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Wang, Liewei, Ellsworth, Katarzyna A., Moon, Irene, Pelleymounter, Linda L., Eckloff, Bruce W., Martin, Yvette N., Fridley, Brooke L., Jenkins, Gregory D., Batzler, Anthony, Suman, Vera J., Ravi, Saranya, Dixon, J. Michael, Miller, William R., Wieben, Eric D., Buzdar, Aman, M.Weinshilboum, Richard, Ingle, James N.
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2804935/
https://ncbi.nlm.nih.gov/pubmed/20048079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-09-3224
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares